Provista Diagnostics (PDx) Announces Formation of Scientific Advisory Board

Published: Jun 28, 2012

Scottsdale, AZ, June 28, 2012 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a provider of oncology-based diagnostic tests and clinical laboratory services to the pharmaceutical and biotechnology industries, announced today the formation of a Scientific Advisory Board (SAB) comprised of recognized leaders in the fields of oncology and biomarker research. The SAB, which includes physicians and medical researchers, will provide critical strategic input on scientific, clinical, product development and commercialization matters.

Back to news